These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12113889)

  • 21. A new approach for increasing ascorbyl palmitate stability by addition of non-irritant co-antioxidant.
    Gosenca M; Obreza A; Pečar S; Gašperlin M
    AAPS PharmSciTech; 2010 Sep; 11(3):1485-92. PubMed ID: 20845090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dioleylphosphatidylcholine increases the antioxidant properties of ascorbyl palmitate in bulk oils compared to other hydrophilic and lipophilic antioxidants.
    Kim H; Woo Y; Choi H; Kim MJ; Lee J
    Food Chem; 2021 Jul; 349():129082. PubMed ID: 33548885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
    Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
    Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanostructures from alkyl vitamin C derivatives (ASCn): properties and potential platform for drug delivery.
    Palma S; Manzo R; Lo Nostro P; Allemandi D
    Int J Pharm; 2007 Dec; 345(1-2):26-34. PubMed ID: 17964094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of ascorbyl palmitate by surfactant-coated lipase in organic media.
    Hsieh HJ; Nair GR; Wu WT
    J Agric Food Chem; 2006 Aug; 54(16):5777-81. PubMed ID: 16881677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental and theoretical investigation of the micellar-assisted solubilization of ibuprofen in aqueous media.
    Stephenson BC; Rangel-Yagui CO; Pessoa Junior A; Tavares LC; Beers K; Blankschtein D
    Langmuir; 2006 Feb; 22(4):1514-25. PubMed ID: 16460069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies in the design of solution-stable, water-soluble prodrugs II: properties of micellar prodrugs of methylprednisolone.
    Anderson BD; Conradi RA; Knuth KE; Nail SL
    J Pharm Sci; 1985 Apr; 74(4):375-81. PubMed ID: 3998997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A diffusion-ordered NMR spectroscopy study of the solubilization of artemisinin by octanoyl-6-O-ascorbic acid micelles.
    Bilia AR; Bergonzi MC; Vincieri FF; Lo Nostro P; Morris GA
    J Pharm Sci; 2002 Oct; 91(10):2265-70. PubMed ID: 12226853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of micellar solubilization of antibiotics using micellar electrokinetic chromatography.
    Mrestani Y; Marestani Z; Neubert RH
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):883-9. PubMed ID: 11600300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micellar distribution equilibria: ultracentrifugal study of apparent partition coefficients.
    Park JY; Rippie EG
    J Pharm Sci; 1977 Jun; 66(6):858-61. PubMed ID: 17721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystallographic and Energetic Insights into Reduced Dissolution and Physical Stability of a Drug-Surfactant Salt: The Case of Norfloxacin Lauryl Sulfate.
    Guo Y; Mishra MK; Wang C; Sun CC
    Mol Pharm; 2020 Feb; 17(2):579-587. PubMed ID: 31829631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dilute solution properties of clindamycin 2-palmitate hydrochloride.
    Abbott TI; Benton DP; Hampson CA
    J Pharm Pharmacol; 1977 Sep; 29(9):529-32. PubMed ID: 21255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Surfactant-Bile Interactions on the Solubility of Hydrophobic Drugs in Biorelevant Dissolution Media.
    Vinarov Z; Katev V; Burdzhiev N; Tcholakova S; Denkov N
    Mol Pharm; 2018 Dec; 15(12):5741-5753. PubMed ID: 30351956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of Caffeic Acid with SDS Micellar Aggregates.
    Cid A; Moldes OA; Mejuto JC; Simal-Gandara J
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotubes from a vitamin C-based bolaamphiphile.
    Ambrosi M; Fratini E; Alfredsson V; Ninham BW; Giorgi R; Lo Nostro P; Baglioni P
    J Am Chem Soc; 2006 Jun; 128(22):7209-14. PubMed ID: 16734474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzymatic synthesis and antioxidant properties of L-ascorbyl oleate and L-ascorbyl linoleate.
    Song QX; Wei DZ; Zhou WY; Xu WQ; Yang SL
    Biotechnol Lett; 2004 Dec; 26(23):1777-80. PubMed ID: 15672213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
    Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
    Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.